查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1937627

全球醫療保健合約研究組織 (CRO) 市場規模、佔有率、趨勢和成長分析報告，2026-2034 年

Global Healthcare Contract Research Outsourcing Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 146 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年，醫療保健合約研究外包 (CRO) 市場規模將從 2025 年的 613.7 億美元成長至 1,154.1 億美元，2026 年至 2034 年的複合年成長率為 7.27%。

受臨床研究和藥物開發領域對高效且經濟的解決方案需求不斷成長的推動，醫療保健合約研究外包 (CRO) 市場預計將顯著成長。製藥和生技公司越來越依賴 CRO 的專業見解和資源，以期簡化營運並加快新治療方法的上市速度。隨著越來越多的機構致力於增強其研究能力，對包括臨床試驗管理、數據分析和法規支援在內的各種服務的需求正在激增。

技術和數據管理創新正在塑造醫療保健CRO市場的未來。進階分析、人工智慧和機器學習的整合使CRO能夠最佳化臨床試驗設計、改善患者招募並增強資料完整性。此外，分散式臨床試驗和遠距監查解決方案的興起正在改變研究的進行方式，提高資料收集的柔軟性和效率。在不斷變化的法規環境下，CRO越來越重視合規性和品質保證，以滿足監管機構的嚴格要求。

此外，醫療保健CRO市場將受益於CRO、製藥公司和學術機構之間合作的加強，從而促進創新並改善研究成果。隨著環境的演變，重點將轉向建構策略夥伴關係，以充分發揮各相關人員的優勢，進而提高整個藥物研發過程的效率。以患者為中心的方法和對真實世界證據的重視也將對塑造醫療保健CRO服務的未來發揮關鍵作用，確保臨床研究符合患者的需求和偏好。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球醫療保健合約研究外包 (CRO) 市場：按服務分類

  • 市場分析、洞察與預測
  • 臨床試驗服務
  • 監管服務
  • 臨床數據管理和生物統計學
  • 醫用照明
  • 藥物監測
  • 網站管理通訊協定
  • 其他

第5章 全球醫療保健合約研究外包 (CRO) 市場：按治療領域分類

  • 市場分析、洞察與預測
  • 腫瘤科/血液科
  • 中樞神經系統
  • 循環系統/代謝疾病領域
  • 呼吸系統
  • 感染疾病
  • 免疫學
  • 罕見疾病
  • 醫療設備
  • 其他

第6章 全球醫療保健合約研究外包 (CRO) 市場：按最終用戶分類

  • 市場分析、洞察與預測
  • 製藥公司
  • 生技公司
  • 醫療設備製造商
  • 學術機構及政府機構

第7章 全球醫療保健合約研究組織 (CRO) 市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Syneos Health
    • PAREXEL International
    • ICON Plc
    • PRA Health Sciences Inc
    • Charles River
    • Laboratory Corporation Of America Holdings（Covance）
    • IQVIA
    • Medpace
    • Pharmaceutical Product Development LLC
簡介目錄
Product Code: VMR11215366

The Healthcare Contract Research Outsourcing Market size is expected to reach USD 115.41 Billion in 2034 from USD 61.37 Billion (2025) growing at a CAGR of 7.27% during 2026-2034.

The healthcare contract research outsourcing (CRO) market is poised for substantial growth, driven by the increasing demand for efficient and cost-effective solutions in clinical research and drug development. As pharmaceutical and biotechnology companies seek to streamline their operations and reduce time-to-market for new therapies, the reliance on CROs for specialized expertise and resources is becoming more prevalent. The market is witnessing a surge in demand for a wide range of services, including clinical trial management, data analysis, and regulatory support, as organizations aim to enhance their research capabilities.

Innovations in technology and data management are shaping the future of the healthcare CRO market. The integration of advanced analytics, artificial intelligence, and machine learning is enabling CROs to optimize clinical trial designs, improve patient recruitment, and enhance data integrity. Additionally, the rise of decentralized clinical trials and remote monitoring solutions is transforming the way research is conducted, allowing for greater flexibility and efficiency in data collection. As regulatory environments evolve, CROs are increasingly focusing on compliance and quality assurance to meet the stringent requirements of health authorities.

Moreover, the healthcare CRO market will benefit from increased collaboration between CROs, pharmaceutical companies, and academic institutions to foster innovation and improve research outcomes. As the landscape evolves, the focus will shift towards developing strategic partnerships that leverage the strengths of each stakeholder, enhancing the overall efficiency of the drug development process. The emphasis on patient-centric approaches and real-world evidence will also play a crucial role in shaping the future of healthcare CRO services, ensuring that clinical research aligns with the needs and preferences of patients.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Service

  • Clinical Trial Service
  • Regulatory Service
  • Clinical Data Management & Biometrics
  • Medical Writing
  • Pharmacovigilance
  • Site Management Protocol
  • Others

By Therapeutic Area

  • Oncology / Hematology
  • CNs
  • CV/Metabolic
  • Respiratory
  • Infectious Diseases
  • Immunology
  • Rare Diseases
  • Medical Devices
  • Others

By End-user

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Companies
  • Academic Institutes & Government Organizations

COMPANIES PROFILED

  • Syneos Health, PAREXEL International, ICON plc, PRA Health Sciences Inc, Charles River, Laboratory Corporation of America Holdings Covance, IQVIA, Medpace, Pharmaceutical Product Development LLC

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET: BY SERVICE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Service
  • 4.2. Clinical Trial Service Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Regulatory Service Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Clinical Data Management & Biometrics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Medical Writing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Pharmacovigilance Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Site Management Protocol Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Therapeutic Area
  • 5.2. Oncology / Hematology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. CNs Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. CV/Metabolic Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Respiratory Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.8. Rare Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.9. Medical Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.10. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Medical Device Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Academic Institutes & Government Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Service
    • 7.2.2 By Therapeutic Area
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Service
    • 7.3.2 By Therapeutic Area
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Service
    • 7.4.2 By Therapeutic Area
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Service
    • 7.5.2 By Therapeutic Area
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Service
    • 7.6.2 By Therapeutic Area
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Syneos Health
    • 9.2.2 PAREXEL International
    • 9.2.3 ICON Plc
    • 9.2.4 PRA Health Sciences Inc
    • 9.2.5 Charles River
    • 9.2.6 Laboratory Corporation Of America Holdings (Covance)
    • 9.2.7 IQVIA
    • 9.2.8 Medpace
    • 9.2.9 Pharmaceutical Product Development LLC